Trials / Not Yet Recruiting
Not Yet RecruitingNCT06286215
Registry of Patients With Plasma Cell Disorders
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 750 (estimated)
- Sponsor
- Siriraj Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to register patients with plasma cell disorders. The main questions it aims to answer are: * The incidence of plasma cell disorders both before and after malignancy * Time to progression of monoclonal gammopathy of undetermined significant (MGUS) or smoldering multiple myeloma (SMM) to light chain amyloidosis or multiple myeloma (MM) * Progression free survival (PFS) * overall survival * factors influencing overall survival, progression-free survival, and time to progression * Symptoms and signs of the disease during the diagnosis and relapse phases, including the causes of mortality in plasma cell disorder patients. * genetic characteristics of plasma cell disorder * cost-effectiveness of treatment in Thailand Participants will be collected the data of baseline diagnosis, treatment, treatment results of all admission and follow-up visits from hospital medical record.
Conditions
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2034-04-01
- Completion
- 2035-04-01
- First posted
- 2024-02-29
- Last updated
- 2024-02-29
Source: ClinicalTrials.gov record NCT06286215. Inclusion in this directory is not an endorsement.